Interview with Yves Groult, Managing Director, Boiron Hungary
Hungary has one of the oldest drug industries in Europe, but homeopathy too has quite a history in the country, with the Homoeopathic Doctor’s Association being founded as early as…
Address: Ady Endre Ut 8 H-1024 Budapest,Hungary
Tel: +36 1 365 1430
Company allapillére way back to health with concrete ideas. More than 50 countries throughout the world for thousands of people’s determination and dedication mean performance is key.
French company, we are szakterületünkön, the world leader in homeopathic medicines. In France, four manufacturing sites and 32 industrial preparation and marketing of a need.
The company – like other companies – currently live in troubled times, but we are confident that it can bring positive changes in the long run, especially in medicine, but the pharmaceutical industry and health care management field.
As a family company we make every effort to adapt to the industry’s difficulties. Humbly, but we try to give you a chance gyógyszereinknek determination, to show their usefulness and efficiency. The French pharmaceutical market is less than 1% of you have … this shows how much we have the opportunity to grow!
A homeopathic preparation of a mono (rarely more) ingredients. The raw material of plant, mineral and animal origin can be.
The Latin name of the homeopathic remedies, the main raw material used to manufacture internationally known scientific names. The Latin name is due to the international homeopathic medicines in all countries of the same name.
The number on the tube dilution őstinktúra your area. The initials represent the type of dilution (C = one hundred times (centezimális) dilution, H = Hahnemann method of preparation)
The mono homeopathic preparations usually used several times in tubes or pellets számlálós-dose disposable containers, and sometimes liquid droplets (or őstinktúra homeopathic dilution) in the form can be purchased. The pharmaceutical industry is also found in other forms of production in homeopathy, but expect much less widespread.
Hungary has one of the oldest drug industries in Europe, but homeopathy too has quite a history in the country, with the Homoeopathic Doctor’s Association being founded as early as…
One of the most salient challenges crippling Hungary’s effort to move the health agenda forward is the mass exodus of healthcare practitioners—placing significant pressures on an already overwhelmed system. “If…
Hungary operates under a state-owned universal National Health Insurance Fund (OEP), completely financed through mandatory tax contributions from employers and employees. “From a drug reimbursement point of view, we have…
Hungarian collector and producer of blood plasma and plasma-derived therapies HUMAN BioPlazma is rooted in over 60 years of history within the country, but only in 2008, with the influence…
While pharmaceutical products and healthcare financing dominate the majority of discussions surrounding the improvement of health outcomes, health literacy still remains a core issue that, if left unaddressed, may vary…
Preventive healthcare and health literacy are core issues in Hungary that, if left unaddressed, may hinder the country’s ability to push its health agenda forward and create a more sustainable…
Smaller pharma companies in Hungary are looking to new unconventional methods of OTC promotion to sidestep the country’s somewhat restrictive reimbursement scheme and compete with major players in the market. Especially in…
The President of the Doctoral Council of Semmelweis University, Dr. József Timár provides an overview of the healthcare system in Hungary with particular reference to oncology and describes the challenges…
LEO Pharma Hungary’s Andrea Bondár demonstrates the significance of adopting non-traditional methods of promotional activities, and defines how a true intent on understanding the psyche of patients suffering from chronic…
Anita Ordog, GM of Angelini Hungary, discusses the affiliate’s history in the country, their expanding OTC and specialty products portfolio, targeted marketing and sales strategies, and Angelini’s challenging entrance into…
Dr. Lívia Ilku, director of Hungary’s main domestic pharmaceutical manufacturers’ association (MAGYOSZ), describes the current priorities of its member companies and the key factors for success in Hungary; specifically innovation…
Prof. Dr. István Vályi-Nagy, Director General of the United St. Istvan and St. Laszlo Hospitals, shares his insights on running one of the largest hospitals in Hungary and the challenges…
The Managing Director of HUMAN BioPlazma, Ákos Tóth, highlights the transformational growth that the business has experienced since becoming a part of Kedrion Biopharma in 2008, while pinpointing the strategic…
See our Cookie Privacy Policy Here